CLINICAL METHOD FOR DETERMINING LUNG ARTERY THROMBOEMBOLISM OCCURRENCE PROBABILITY IN PATIENTS SUFFERING FROM SINUS NODE ASTHENIA WITH ADJUSTED ELECTROCARDIOSTIMULATOR Russian patent published in 2007 - IPC A61B10/00 

FIELD: medicine.

SUBSTANCE: method involves determining clinical signs like alternate diagnosis probability and hemoptysis availability. Score estimate is found for each of them to be equal to 3 and 1, respectively. Diagnosis based on their sum is built with additional clinical signs being determined: two typical respiratory and/or cardiac lung artery thromboembolism symptoms estimated with scores equal to 3. Score 1.5 is assigned to atrial fibrillation signs available on electrocardiogram. Score 1 is given to the fact of electrocardiostimulator implantation occurred within preceding 6 months. Upper extremity vein thrombosis after electrocardiostimulator implantation is estimated with score 1.5. Score 1 is assigned to II type sinus node asthenia. Single chamber ventricular stimulation is estimated with score 1. Availability of one or several risk factors is evaluated with score 1. Lack of any of mentioned signs is estimated with score 0. Sum of scores is calculated. The sum being greater than 6, high clinical probability of lung artery thromboembolism is diagnosed. The value being from 2 to 6, medium clinical probability is the case. The value being less than 2, the probability is considered to be low.

EFFECT: high accuracy and reliability of the method.

1 tbl